Published :
Report ID:
Pages :
Format :
The global DNA sequencing market is anticipated to grow at a CAGR of around 19.9% during the forecast period 2020 to 2027 and to reach around US$ 37.6 Bn by 2027.
Market Dynamics
High government spending on development of present healthcare infrastructure, increasing R&D activities related to development of DNA analysis technology, coupled with innovative product offerings by major players are factor expected to drive the growth of global market. In addition, increasing prevalence of chronic diseases across the globe, rising demand for advanced diagnostic solutions is resulting in resulting in demand for DNA sequencing solutions due to its applicability in diagnostics and biomarkers & cancer is another important factor expected to support the growth of target market.
Players are investing high for product development along with innovative product offerings in order to attract new customers is another important factor expected to further support the growth of target market.
In addition, players approach towards strategic business expansion through partnerships and agreements is another factor expected to further support the growth of target market.
However, factor such as rising concern related to data security and high cost of equipments are expected to hamper the growth of global DNA sequencing market. In addition, lack of skilled expertise is another important factor expected to further support the growth of target market.
High investment for technological advancements and major player’s inclination towards developing countries in order to track the untapped market are factors expected to create new opportunities for players operating in the target market over the forecast period.
DNA Sequencing Market Segment Analysis, 2019
The global DNA sequencing market is further segmented into product, application, technology, and end user. The technology segment is further bifurcated into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single-molecule real-time sequencing, chain termination sequencing, and nanopore sequencing. Among end use the biotechnology companies segment is expected to account for significant revenue share in the global market.
Segment Analysis by Region
The market in North America is expected to account for significant revenue share owing to high patient pool suffering from chronic diseases and rising demand for advanced diagnostic solutions. In addition, increasing government spending on development of healthcare sector, high investment by major players for R&D activities, coupled with innovative product offerings are among other factors expected to further support the growth of regional market.
Asia Pacific is expected to witness faster growth in the near future owing to increasing government spending on development healthcare infrastructure. In addition, developing regulatory scenario and major player’s inclination towards emerging economies in order to increase the business presence is another important factor expected to further support the growth of target market.
Competitive Landscape
The global market is high highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.
Report coverage
Market |
Global DNA Sequencing Market |
Analysis Period |
2016 – 2027 |
Base Year |
2019 |
Forecast Data |
2020 – 2027 |
Market Stratification |
Product, Application, Technology, End User and Geography |
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Report Coverage |
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
The market research study on “DNA Sequencing Market (Product: Consumable, Instrument, and Service; Application: Diagnostics, Biomarkers & Cancer, Reproductive Health, Personalized Medicine, Forensics, and Others; Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single-molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing; End Use: Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027”, offers a detailed insights on the global DNA sequencing market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights on global DNA sequencing market segment by product, application, technology, end user and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global DNA sequencing market size and segment markets by product, application, technology, end user and geography along with the information on companies operating in the market. The DNA sequencing market analysis is provided for major regional market including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. For each region, the market size for different segments has been covered under the scope of report. The players profiled in the report Macrogen, Inc., Oxford Nanopore Technologies, Ltd., Bio-Rad Laboratories, Inc., Eurofins Scientific, Gatc Biotech AG, DNASTAR, Inc., Biomatters Ltd., New England Biolabs, Inc., and Myriad Genetics, Inc.
Market Segmentation
Market By Product
Market By Technology
Market By Application
Market By End Use
Market By Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
The DNA sequencing market value is anticipated to be worth around US$ 19.9 Bn in 2027.
The DNA sequencing market is anticipated to grow around 37.6% CAGR amid the forecast period 2020-2027.
The key players operating in DNA sequencing market such as Macrogen, Inc., Oxford Nanopore Technologies, Ltd., Bio-Rad Laboratories, Inc., Eurofins Scientific, Gatc Biotech AG, DNASTAR, Inc., Biomatters Ltd., New England Biolabs, Inc., and Myriad Genetics, Inc.
In end use segment the biotechnology companies is growing at faster pace.
In the global market the Asia Pacific region is expected to grow faster
The report provides insights on global DNA sequencing market segment by product, technology, application, end use, and major geographic regions.
The DNA sequencing market analysis is provided for major regional market including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.